News

Oxytocin's neuroprotective role against GLP-1-a...

Postmenopausal women using GLP-1 agonists for weight loss may face accelerated bone loss. Oxytocin, a neuropeptide with osteoanabolic properties

Kisspeptin as a neuroendocrine strategy to coun...

GLP-1 agonists like semaglutide and tirzepatide can disrupt menstrual cycles by suppressing hypothalamic kisspeptin. Research explores kisspeptin and